ERBB2 and osteosarcoma: In the same trial, another group of patients was treated with HER2 CAR T cells after lymphodepletion, including five patients with osteosarcoma, three with rhabdomyosarcoma, and one patient each with Ewing’s sarcoma or synovial sarcoma.